How To Address Challenges In Oncology Drug Containment
By T. Page McAndrew
Drug product containment systems comprising Daikyo Crystal Zenith® cyclic olefin polymer (COP) vials have advantages over those comprising glass vials. When matched with NovaPure® stoppers, container closure integrity (CCI) performance has been quantified for oxygen and carbon dioxide, at temperatures from room temperature through cryogenic temperatures, with excellent system performance. For these reasons, they are an excellent choice for oncology therapies, in particular those based on gene and cell therapies that require cryogenic storage.
VIEW THE ARTICLE! Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X
Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.
Subscribe to Biosimilar Development X
Subscribe to Biosimilar Development